Seven out of every ten patients with non-alcoholic fatty liver disease feel stigmatized
The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deteriorat...
The study, in which Hospital Clínic-IDIBAPS researchers have participated, shows that the perception of this stigma is associated with a deteriorat...
The consortium has begun the second clinical trial to evaluate the efficiency of the combined treatment of simvastatin and the antibiotic rifaximin...
Professionals from the Hospital Clínic-IDIBAPS and CIBEREHD participated in the preparation of the international guidelines produced by the America...
A study led by researchers from the Clínic-IDIBAPS and the CIBEREHD and published in the Journal of Hepatology shows that up to 9% of patients with...
A study coordinated by researchers of the Clínic-IDIBAPS and published in The Lancet Gastroenterology & Hepatology establishes the safe dose of sim...
